Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Heuser

Showing results (251-260 of 280) with videos related to

Pageof 28
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 4, 2019
Valproate and Retinoic Acid in Combination With Decitabine in Elderly Nonfit Patients With Acute Myeloid Leukemia: Results of a Multicenter, Randomized, 2 × 2, Phase II TrialMichael Lübbert, Olga Grishina, Claudia Schmoor, et al.
Blood|January 6, 2026
Phase 3 study of intensive chemotherapy with or without dasatinib in core-binding factor acute myeloid leukemiaHartmut Döhner, Daniela Späth, Maral Saadati, et al.
Journal of Hematology & Oncology|August 19, 2024
Genomic characterization of AML with aberrations of chromosome 7: a multinational cohort of 519 patientsAdriane Halik, Marlon Tilgner, Patricia Silva, et al.
Science Translational Medicine|November 26, 2025
Lymphotoxin alpha eradicates acute myeloid leukemia and simultaneously promotes healthy hematopoiesis in miceUlrike Höckendorf, Sayantanee Dutta, Arnold Kloos, et al.
Leukemia|January 14, 2026
Unravelling co-mutational patterns with prognostic implications in NPM1 mutated adult acute myeloid leukemia - a HARMONY studyAlberto Hernández-Sánchez, Ángela Villaverde Ramiro, Eric Sträng, et al.
European Journal of Haematology|October 14, 2024
Impact of TP53 Mutation Status in Elderly AML Patients When Adding All-Trans Retinoic Acid or Valproic Acid to DecitabineHelena Bresser, Claudia Schmoor, Olga Grishina, et al.
Blood|December 20, 2018
Midostaurin added to chemotherapy and continued single-agent maintenance therapy in acute myeloid leukemia with <i>FLT3</i>-ITDRichard F Schlenk, Daniela Weber, Walter Fiedler, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 8, 2018
Role of Donor Clonal Hematopoiesis in Allogeneic Hematopoietic Stem-Cell TransplantationMareike Frick, Willy Chan, Christopher Maximilian Arends, et al.
The Lancet. Haematology|May 15, 2023
Intensive chemotherapy with or without gemtuzumab ozogamicin in patients with NPM1-mutated acute myeloid leukaemia (AMLSG 09-09): a randomised, open-label, multicentre, phase 3 trialHartmut Döhner, Daniela Weber, Julia Krzykalla, et al.
Leukemia|January 29, 2021
Germline variants drive myelodysplastic syndrome in young adultsSimone Feurstein, Jane E Churpek, Tom Walsh, et al.
Pageof 28

Showing results (251-260 of 280) with videos related to

Sort By:
Pageof 28
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 4, 2019
Valproate and Retinoic Acid in Combination With Decitabine in Elderly Nonfit Patients With Acute Myeloid Leukemia: Results of a Multicenter, Randomized, 2 × 2, Phase II TrialMichael Lübbert, Olga Grishina, Claudia Schmoor, et al.
Blood|January 6, 2026
Phase 3 study of intensive chemotherapy with or without dasatinib in core-binding factor acute myeloid leukemiaHartmut Döhner, Daniela Späth, Maral Saadati, et al.
Journal of Hematology & Oncology|August 19, 2024
Genomic characterization of AML with aberrations of chromosome 7: a multinational cohort of 519 patientsAdriane Halik, Marlon Tilgner, Patricia Silva, et al.
Science Translational Medicine|November 26, 2025
Lymphotoxin alpha eradicates acute myeloid leukemia and simultaneously promotes healthy hematopoiesis in miceUlrike Höckendorf, Sayantanee Dutta, Arnold Kloos, et al.
Leukemia|January 14, 2026
Unravelling co-mutational patterns with prognostic implications in NPM1 mutated adult acute myeloid leukemia - a HARMONY studyAlberto Hernández-Sánchez, Ángela Villaverde Ramiro, Eric Sträng, et al.
European Journal of Haematology|October 14, 2024
Impact of TP53 Mutation Status in Elderly AML Patients When Adding All-Trans Retinoic Acid or Valproic Acid to DecitabineHelena Bresser, Claudia Schmoor, Olga Grishina, et al.
Blood|December 20, 2018
Midostaurin added to chemotherapy and continued single-agent maintenance therapy in acute myeloid leukemia with <i>FLT3</i>-ITDRichard F Schlenk, Daniela Weber, Walter Fiedler, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 8, 2018
Role of Donor Clonal Hematopoiesis in Allogeneic Hematopoietic Stem-Cell TransplantationMareike Frick, Willy Chan, Christopher Maximilian Arends, et al.
The Lancet. Haematology|May 15, 2023
Intensive chemotherapy with or without gemtuzumab ozogamicin in patients with NPM1-mutated acute myeloid leukaemia (AMLSG 09-09): a randomised, open-label, multicentre, phase 3 trialHartmut Döhner, Daniela Weber, Julia Krzykalla, et al.
Leukemia|January 29, 2021
Germline variants drive myelodysplastic syndrome in young adultsSimone Feurstein, Jane E Churpek, Tom Walsh, et al.
Pageof 28